Development of magnetic capture hybridization and quantitative polymerase chain reaction for hepatitis B virus covalently closed circular DNA

Hepatitis Monthly

Volumn 15, Issue 1, 2015, Pages 1-9

  Guo, Yongcan ^a   Sheng, Shangchun ^a   Nie, Bin ^a   Tu, Zhiguang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Magnetic; PCR technology

Indexed keywords

CIRCULAR DNA; MAGNETIC NANOPARTICLE; OLIGONUCLEOTIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LINEARITY; MAGNETIC CAPTURE HYBRIDIZATION; MEASUREMENT REPEATABILITY; NUCLEIC ACID ANALYSIS; QUALITY CONTROL; QUANTITATIVE POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84920946579     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.23729     Document Type: Article

References (35)

1. Behnava B, Assari S, Amini M, Hajibeigi B, Jouybari HM, Alavian SM. HBV DNA viral load and chronic hepatitis infection in different stages. Hepat Mon. 2005;5(4):123-7.
2. Schmidt J, Blum HE, Thimme R. T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerg Microbes Infect. 2013;2(3).
3. Mazet-Wagner AA, Baclet MC, Loustaud-Ratti V, Denis F, Alain S. Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients. J Virol Methods. 2006;138(1-2):70-9.
4. Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L, Ciotti M, et al. Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig Liver Dis. 2010;42(8):578-84.
5. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology. 2004;126(7):1750-8.
6. Bourne EJ, Dienstag JL, Lopez VA, Sander TJ, Longlet JM, Hall JG, et al. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat. 2007;14(1):55-63.
7. Grimm D, Thimme R, Blum HE. HBV life cycle and novel drug targets. Hepatol Int. 2011;5(2):644-53.
8. Xu CH, Li ZS, Dai JY, Zhu HY, Yu JW, Lu SL. Nested real-time quantitative polymerase chain reaction assay for detection of hepatitis B virus covalently closed circular DNA. Chin Med J (Engl). 2011;124(10):1513-6.
9. Jun-Bin S, Zhi C, Wei-Qin N, Jun F. A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. J Virol Methods. 2003;112(1-2):45-52.
10. Gao YT, Han T, Li Y, Yang B, Wang YJ, Wang FM, et al. Enhanced specificity of real-time PCR for measurement of hepatitis B virus cccDNA using restriction endonuclease and plasmid-safe ATP-dependent DNase and selective primers. J Virol Methods. 2010;169(1):181-7.
11. He ML, Wu J, Chen Y, Lin MC, Lau GK, Kung HF. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun. 2002;295(5):1102-7.
12. Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology. 1996;23(3):405-13.
13. Caruntu FA, Molagic V. CccDNA persistence during natural evolution of chronic VHB infection. Rom J Gastroenterol. 2005;14(4):373-7.
14. Parham NJ, Picard FJ, Peytavi R, Gagnon M, Seyrig G, Gagne PA, et al. Specific magnetic bead based capture of genomic DNA from clinical samples: application to the detection of group B streptococci in vaginal/anal swabs. Clin Chem. 2007;53(9):1570-6.
15. Archer MJ, Lin B, Wang Z, Stenger DA. Magnetic bead-based solid phase for selective extraction of genomic DNA. Anal Biochem. 2006;355(2):285-97.
16. Mahdavi M, Ahmad MB, Haron MJ, Namvar F, Nadi B, Rahman MZ, et al. Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applications. Molecules. 2013;18(7):7533-48.
17. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611-22.
18. Valentine-Thon E, van Loon AM, Schirm J, Reid J, Klapper PE, Cleator GM. European proficiency testing program for molecular detection and quantitation of hepatitis B virus DNA. J Clin Microbiol. 2001;39(12):4407-12.
19. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009;51(3):581-92.
20. Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR. J Virol Methods. 2004;118(2):159-67.
21. Guo Y, Li Y, Mu S, Zhang J, Yan Z. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication. J Med Virol. 2009;81(7):1177-83.
22. Yuen MF, Wong DK, Sum SS, Yuan HJ, Yuen JC, Chan AO, et al. Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection. Am J Gastroenterol. 2005;100(5):1099-103.
23. Chen Y, Sze J, He ML. HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage. World J Gastroenterol. 2004;10(1):82-5.
24. Vijayakumar R, Koltypin Y, Felner I, Gedanken A. Sonochemical synthesis and characterization of pure nanometer-sized Fe< sub> 3 O< sub> 4 particles. Mater Sci Eng. 2000;286(1):101-5.
25. Sun Y, Duan L, Guo Z, DuanMu Y, Ma M, Xu L, et al. An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application. J Magn Magn Mater. 2005;285(1):65-70.
26. Rossi LM, Shi L, Quina FH, Rosenzweig Z. Stober synthesis of monodispersed luminescent silica nanoparticles for bioanalytical assays. Langmuir. 2005;21(10):4277-80.
27. Schiestel T, Brunner H, Tovar GE. Controlled surface functionalization of silica nanospheres by covalent conjugation reactions and preparation of high density streptavidin nanoparticles. J Nanosci Nanotechnol. 2004;4(5):504-11.
28. Caswell KK, Wilson JN, Bunz UH, Murphy CJ. Preferential end-toend assembly of gold nanorods by biotin-streptavidin connectors. J Am Chem Soc. 2003;125(46):13914-5.
29. Chinese Society of Infectious Diseases and Parasitology CSOH. Management scheme of diagnostic and therapy criteria of viral hepatitis. Chin J Hepatol. 2000;6:324-9.
30. Trachslin J, Koch M, Chiquet M. Rapid and reversible regulation of collagen XII expression by changes in tensile stress. Exp Cell Res. 1999;247(2):320-8.
31. Borlido L, Azevedo AM, Roque AC, Aires-Barros MR. Magnetic separations in biotechnology. Biotechnol Adv. 2013;31(8):1374-85.
32. Chou CC, Chen CH, Lee TT, Peck K. Optimization of probe length and the number of probes per gene for optimal microarray analysis of gene expression. Nucleic Acids Res. 2004;32(12).
33. Takkenberg RB, Zaaijer HL, Molenkamp R, Menting S, Terpstra V, Weegink CJ, et al. Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients. J Med Virol. 2009;81(6):988-95.
34. Xia Y, Lucifora J, Reisinger F, Heikenwalder M, Protzer U. Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA". Science. 2014;344(6189):1237.
35. Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol. 2003;77(17):9511-21.